FDA Advisers Raise Doubts About Experimental ALS Drug 0 31.03.2022 00:54 The Wall Street Journal The advisory committee voted 6-to-4 that there wasn’t enough evidence from the single clinical trial to find that Amylyx Pharmaceuticals’ drug works. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
